Notch signaling antagonizes a proneural alternative splicing program in the embryonic cerebral cortex
Notch signaling antagonizes a proneural alternative splicing program in the embryonic cerebral cortex
批准号:
369055984
负责人:
Privatdozentin Dr. Jennifer Winter, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In embryonic neurogenesis the balance has to be kept between neural stem cell self renewal and neuronal differentiation. Precocious neuronal differentiation causes premature exhaustion of the stem cell pool and can lead to disorders like microcephaly. Notch signaling antagonizes precocious neuronal differentiation. Notch signaling activates the expression of the Hes/Hey transcriptional repressors thereby counteracting the expression of proneural transcription factors, e.g. Neurogenin 2. Although this principle is known already for a long time surprisingly few targets of Hes/Hey repressors have been identified in the embryonic brain and thus the molecular mechanisms downstream of Notch signaling are only poorly understood.With a bioinformatics approach we have predicted Hes/Hey target genes genomwide. A gene ontology analysis of these putative Hes/Hey targets revealed an enrichment of RNA processing factors among the predicted targets. Four of the targets, Ptbp2, Rbfox2, hnRNP F and Srpk1, are all alternative splicing factors. An analysis of published expression data revealed co-expression of all four factors in the embryonic cerebral cortex suggesting a function during neurogenesis. A comparative analysis of the expression of Rbfox2 and Hes5 in the embryonic cerebral cortex via immunostaining revealed a mutually exclusive expression pattern. In addition, luciferase reporter assays confirmed the functionality of the Hes/Hey binding sites in the Rbfox2 promoter. To elucidate the importance of Rbfox2 repression in neural stem cells we overexpressed Rbfox2 in normally Rbfox2 negative, Hes5 positive progenitors in vivo. Rbfox2 expressing Pax positive neural stem cells prematurely migrated out of the ventricular zone. Furthermore Rbfox2 overexpression increased the proportion of Tbr2 positive basal progenitors and decreased the proportion of Tbr1 positive neurons suggesting a shift towards indirect neurogenesis. These preliminary results suggest that Notch signaling plays a so far unknown but important role during the regulation of proneural alternative splicing. Based on these results we want to answer the following questions: Which alternative splicing decisions are regulated by Notch signaling in neural progenitor cells (aim 1)? Are the four splicing factors direct Hes/Hey targets (aim 2)? Is the Notch mediated repression of the four splicing factors essential for neurogenesis (aim 3)?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The functions of the imprinted miR379-410 cluster during neuronal migration in the developing telencephalon
-
批准号:276730358
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Privatdozentin Dr. Jennifer Winter, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
-
批准号:32370928
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:孙钦秒
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: